6 European Projects Found
Searched on 125080 European Projects
FINISHED
TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE-THREATENING FOOD ALLERGIES (FAST)
Start date: Sep 1, 2008, End date: May 31, 2017,
The FAST project aims at the development of safe and effective treatment of food allergies. It targets persistent and severe allergy to fish and fruit. Besides persistence and severity, this choice is based on prevalence and the importance of these foods for a healthy diet. Classical allergen-specific immunotherapy (SIT) for treatment of food allergy using subcutaneous injections with food extract ...
Read Project
19
Partners Participants
FINISHED
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)
Start date: Mar 1, 2012, End date: Feb 28, 2017,
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Read Project
39
Partners Participants
FINISHED
The Dynamic Protein Matrix in Photosynthesis: From Disorder to Life (PHOTPROT)
Start date: Feb 1, 2011, End date: Jan 31, 2017,
In photosynthesis solar light is harvested by an antenna, the energy is transferred to the photosynthetic reaction center where a charge separation occurs. These processes occur on an ultrafast timescale and result in a stable product. The photosynthetic apparatus consists of a complex set of pigment-proteins that perform these delicate processes with a quantum efficiency close to 1. Proteins are ...
Read Project
3
Partners Participants
FINISHED
Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
The trypanosomatid diseases, leishmaniasis, Human African trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (Califor ...
Read Project
14
Partners Participants
FINISHED
TERPENOYLATION: AN ORIGINAL CONCEPT FOR THE DISCOVERY OF NEW NANOMEDICINES (TERNANOMED)
Start date: Jun 1, 2010, End date: May 31, 2015,
Terpenoids are a group of natural compounds that are extraordinary diverse in chemistry, structure and function. Most of the natural terpenoids are flexible and biocompatible biopolymers, having physico-chemical characteristics able to adapt to a wide variety of biologically active compounds. Surprisingly, they have never been used previously in the nanotechnology field for drug delivery and targe ...
Read Project
4
Partners Participants
FINISHED
Reactive oxygen species production and reactive oxygen species mediated signalling (ROS signal)
Start date: Sep 1, 2008, End date: Aug 31, 2010,
Oxygen plays the important role not only in respiration of the organisms. The interaction of oxygen molecules with cell components produces the reactive oxygen species (ROS). ROS is always present in biological cells and their concentration is maintained in continuous level under normal conditions. But the level of ROS increases significantly under stress conditions which may leads to the cells de ...
Read Project
